What is the current annual EBITDA of BSX?

As of today, BSX annual EBITDA is $5.44B

What is 1-year change in BSX annual EBITDA?

BSX annual EBITDA is up +39.32% year-over-year

What is 3-year change in BSX annual EBITDA?

BSX annual EBITDA is up +83.75% over the past 3 years

How far is BSX annual EBITDA from its all-time high?

BSX annual EBITDA is currently at its all-time high

How does BSX annual EBITDA rank versus sector peers?

BSX annual EBITDA is higher than 97.95% of companies in Healthcare sector

When is BSX next annual earnings release?

As of today, the next annual earnings release for BSX has not been scheduled

What is the current quarterly EBITDA of BSX?

As of today, BSX quarterly EBITDA is $1.58B

What is BSX quarterly EBITDA most recent change?

BSX quarterly EBITDA was up +14.03% on December 31, 2025

What is 1-year change in BSX quarterly EBITDA?

BSX quarterly EBITDA is up +68.30% year-over-year

How far is BSX quarterly EBITDA from its all-time high?

BSX quarterly EBITDA is currently at its all-time high

How does BSX quarterly EBITDA rank versus sector peers?

BSX quarterly EBITDA is higher than 98.08% of companies in Healthcare sector

When is BSX next earnings release?

The next earnings release for BSX is on April 22, 2026

What is the current TTM EBITDA of BSX?

As of today, BSX TTM EBITDA is $5.44B

What is BSX TTM EBITDA most recent change?

BSX TTM EBITDA was up +13.34% on December 31, 2025

What is 1-year change in BSX TTM EBITDA?

BSX TTM EBITDA is up +38.61% year-over-year

How far is BSX TTM EBITDA from its all-time high?

BSX TTM EBITDA is currently at its all-time high

How does BSX TTM EBITDA rank versus sector peers?

BSX TTM EBITDA is higher than 97.80% of companies in Healthcare sector

When is BSX next earnings release?

The next earnings release for BSX is on April 22, 2026

BSX EBITDA History & Chart Since 1991

Annual EBITDA

$5.44B$1.54B+39.32%

December 31, 2025

Summary

Current Value: As of today, BSX annual EBITDA is $5.44B, up +39.32% on December 31, 2025
Historical Performance: BSX annual EBITDA is up +83.75% over the past 3 years, up +215.67% over the past 5 years
All-Time High Comparison: BSX annual EBITDA is currently at its all-time high
3-Year Low Comparison: BSX annual EBITDA is +83.75% above its 3-year low of $2.96B reached on an earlier date
Sector Comparison: BSX annual EBITDA is higher than 97.95% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Company, ETF, index, screener or watchlist

Series

Performance

BSX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$5.44B	+39.3%	+83.8%	+215.7%	+187.9%
Quarterly EBITDA	Dec 31, 25	$1.58B	+68.3%	+112.3%	+240.6%	+216.7%
TTM EBITDA	Dec 31, 25	$5.44B	+38.6%	+82.6%	+216.2%	+187.8%
Price	Feb 27, 26	$76.85	-26.0%	+62.6%	+98.3%	+942.7%
PE Ratio	Feb 27, 26	39.63	-52.4%	-62.5%	–	–
Annual Revenue	Dec 31, 25	$20.07B	+19.9%	+58.3%	+102.5%	+157.2%
Annual EPS	Dec 31, 25	$1.94	+55.5%	+334.9%	+2488.1%	+377.0%
Annual EBIT	Dec 31, 25	$3.97B	+50.7%	+117.7%	+560.7%	+270.1%
Annual Net Income	Dec 31, 25	$2.89B	+56.7%	+314.3%	+3626.8%	+371.6%

EBITDA Highs

BSX Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$5.44B	Dec 31, 25	at high
5Y	$5.44B	Dec 31, 25	at high
All	$5.44B	Dec 31, 25	at high

EBITDA Lows

BSX Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$2.96B	N/A	+83.8%
5Y	$1.72B	N/A	+215.7%
All	$73.90M	Dec 31, 91	+7259.9%

EBITDA History

Year	Value	Change
2025	$5.44B	+39.3%
2024	$3.90B	+15.6%
2023	$3.38B	+14.1%
2022	$2.96B	-1.8%
2021	$3.02B	+75.0%
2020	$1.72B	-36.7%
2019	$2.72B	+3.5%
2018	$2.63B	+11.1%
2017	$2.37B	+15.5%
2016	$2.05B	+31.6%
2015	$1.56B	-0.7%
2014	$1.57B	+0.6%
2013	$1.56B	-7.0%
2012	$1.68B	-8.9%
2011	$1.84B	-2.6%
2010	$1.89B	-11.6%
2009	$2.14B	-1.0%
2008	$2.16B	+1.9%

Year	Value	Change
2007	$2.12B	+5.1%
2006	$2.02B	-13.8%
2005	$2.34B	+14.3%
2004	$2.05B	+116.5%
2003	$945.00M	+23.9%
2002	$763.00M	+5.2%
2001	$725.00M	-12.7%
2000	$830.00M	-3.2%
1999	$857.00M	+45.7%
1998	$588.11M	+0.7%
1997	$584.05M	+17.0%
1996	$499.24M	+39.5%
1995	$357.99M	+157.3%
1994	$139.11M	+21.0%
1993	$114.95M	+18.1%
1992	$97.37M	+31.8%
1991	$73.90M	-

FAQ

What is the current annual EBITDA of BSX?
As of today, BSX annual EBITDA is $5.44B
What is 1-year change in BSX annual EBITDA?
BSX annual EBITDA is up +39.32% year-over-year
What is 3-year change in BSX annual EBITDA?
BSX annual EBITDA is up +83.75% over the past 3 years
How far is BSX annual EBITDA from its all-time high?
BSX annual EBITDA is currently at its all-time high
How does BSX annual EBITDA rank versus sector peers?
BSX annual EBITDA is higher than 97.95% of companies in Healthcare sector
When is BSX next annual earnings release?
As of today, the next annual earnings release for BSX has not been scheduled

Quarterly EBITDA

$1.58B$194.00M+14.03%

December 31, 2025

Summary

Current Value: As of today, BSX quarterly EBITDA is $1.58B, up +14.03% on December 31, 2025
Historical Performance: BSX quarterly EBITDA is up +68.30% year-over-year, up +112.25% over the past 3 years
All-Time High Comparison: BSX quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: BSX quarterly EBITDA is +112.25% above its 3-year low of $743.00M reached on an earlier date
Sector Comparison: BSX quarterly EBITDA is higher than 98.08% of companies in Healthcare sector

Performance

BSX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Dec 31, 25	$1.58B	+14.0%	+68.3%	+112.3%	+240.6%
Annual EBITDA	Dec 31, 25	$5.44B	–	+39.3%	+83.8%	+215.7%
TTM EBITDA	Dec 31, 25	$5.44B	+13.3%	+38.6%	+82.6%	+216.2%
Price	Feb 27, 26	$76.85	-22.4%	-26.0%	+62.6%	+98.3%
PE Ratio	Feb 27, 26	39.63	-25.2%	-52.4%	-62.5%	–
Quarterly Revenue	Dec 31, 25	$5.29B	+4.4%	+15.9%	+63.0%	+95.2%
Quarterly EPS	Dec 31, 25	$0.45	-11.0%	+18.3%	+414.1%	+369.0%
Quarterly EBIT	Dec 31, 25	$1.04B	0.0%	+76.7%	+131.8%	+498.3%
Quarterly Net Income	Dec 31, 25	$670.00M	-11.3%	+19.2%	+378.6%	+340.8%

Quarterly EBITDA Highs

BSX Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.58B	Dec 31, 25	at high
3Y	$1.58B	Dec 31, 25	at high
5Y	$1.58B	Dec 31, 25	at high
All	$1.58B	Dec 31, 25	at high

Quarterly EBITDA Lows

BSX Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$937.00M	N/A	+68.3%
3Y	$743.00M	N/A	+112.3%
5Y	$463.00M	N/A	+240.6%
All	-$95.70M	Dec 31, 91	+1747.9%

Quarterly EBITDA History

Month	Value	Change
Dec 2025	$1.58B	+14.0%
Sep 2025	$1.38B	+9.9%
Jun 2025	$1.26B	+3.0%
Mar 2025	$1.22B	+30.3%
Dec 2024	$937.00M	-4.5%
Sep 2024	$981.00M	-7.3%
Jun 2024	$1.06B	+11.6%
Mar 2024	$948.00M	+8.8%
Dec 2023	$871.00M	+1.4%
Sep 2023	$859.00M	+1.2%
Jun 2023	$849.00M	+6.1%
Mar 2023	$800.00M	+7.7%
Dec 2022	$743.00M	-0.1%
Sep 2022	$744.00M	-2.2%
Jun 2022	$761.00M	+4.1%
Mar 2022	$731.00M	-2.1%
Dec 2021	$747.00M	+4.6%
Sep 2021	$714.00M	-7.8%
Jun 2021	$774.00M	+23.2%
Mar 2021	$628.00M	+35.6%
Dec 2020	$463.00M	-14.7%
Sep 2020	$543.00M	+153.7%
Jun 2020	$214.00M	-57.2%
Mar 2020	$500.00M	-28.7%
Dec 2019	$701.00M	+7.2%
Sep 2019	$654.00M	-1.7%
Jun 2019	$665.00M	+1.1%
Mar 2019	$658.00M	-1.6%
Dec 2018	$669.00M	+5.7%
Sep 2018	$633.00M	-4.7%
Jun 2018	$664.00M	-0.3%
Mar 2018	$666.00M	0.0%
Dec 2017	$666.00M	+13.7%
Sep 2017	$586.00M	-2.7%
Jun 2017	$602.00M	+17.1%
Mar 2017	$514.00M	-3.4%
Dec 2016	$532.00M	-1.3%
Sep 2016	$539.00M	+6.1%
Jun 2016	$508.00M	+7.6%
Mar 2016	$472.00M	+436.4%
Dec 2015	$88.00M	-78.5%
Sep 2015	$410.00M	+5.4%
Jun 2015	$389.00M	-3.5%
Mar 2015	$403.00M	+17.8%
Dec 2014	$342.00M	-10.7%
Sep 2014	$383.00M	-2.5%
Jun 2014	$393.00M	+0.3%
Mar 2014	$392.00M	+2.6%
Dec 2013	$382.00M	-1.0%
Sep 2013	$386.00M	-6.5%
Jun 2013	$413.00M	+9.0%
Mar 2013	$379.00M	-12.9%
Dec 2012	$435.00M	+4.6%
Sep 2012	$416.00M	-1.9%
Jun 2012	$424.00M	+5.5%
Mar 2012	$402.00M	-3.1%
Dec 2011	$415.00M	+1.2%
Sep 2011	$410.00M	-14.6%
Jun 2011	$480.00M	-10.3%
Mar 2011	$535.00M	+7.4%
Dec 2010	$498.00M	+6.0%
Sep 2010	$470.00M	+5.1%
Jun 2010	$447.00M	-5.9%
Mar 2010	$475.00M	-12.0%
Dec 2009	$540.00M	+2.5%
Sep 2009	$527.00M	-3.3%
Jun 2009	$545.00M	+21.9%
Mar 2009	$447.00M	-8.8%
Dec 2008	$490.00M	-2.6%
Sep 2008	$503.00M	-9.4%

Month	Value	Change
Jun 2008	$555.00M	-9.0%
Mar 2008	$610.00M	+3.7%
Dec 2007	$588.00M	+15.5%
Sep 2007	$509.00M	-11.3%
Jun 2007	$574.00M	+12.3%
Mar 2007	$511.00M	-8.8%
Dec 2006	$560.00M	+34.0%
Sep 2006	$418.00M	-9.9%
Jun 2006	$464.00M	-19.2%
Mar 2006	$574.00M	+5.7%
Dec 2005	$543.00M	+1.1%
Sep 2005	$537.00M	-11.2%
Jun 2005	$605.00M	-7.4%
Mar 2005	$653.00M	+22.1%
Dec 2004	$535.00M	+14.6%
Sep 2004	$467.00M	-13.2%
Jun 2004	$538.00M	+88.1%
Mar 2004	$286.00M	+26.0%
Dec 2003	$227.00M	+8.1%
Sep 2003	$210.00M	+1.9%
Jun 2003	$206.00M	+5.6%
Mar 2003	$195.00M	-26.4%
Dec 2002	$265.00M	+59.6%
Sep 2002	$166.00M	+15.3%
Jun 2002	$144.00M	+2.1%
Mar 2002	$141.00M	-59.4%
Dec 2001	$347.00M	+144.4%
Sep 2001	$142.00M	+51.1%
Jun 2001	$94.00M	-33.8%
Mar 2001	$142.00M	-32.1%
Dec 2000	$209.00M	+15.5%
Sep 2000	$181.00M	-11.7%
Jun 2000	$205.00M	+6.8%
Mar 2000	$192.00M	-29.4%
Dec 1999	$272.00M	+83.8%
Sep 1999	$148.00M	-34.2%
Jun 1999	$225.00M	+6.1%
Mar 1999	$212.00M	-2.3%
Dec 1998	$216.89M	+65.6%
Sep 1998	$130.97M	+12.9%
Jun 1998	$116.00M	+4.5%
Mar 1998	$111.00M	+142.4%
Dec 1997	$45.80M	-63.2%
Sep 1997	$124.50M	-10.3%
Jun 1997	$138.80M	+23.0%
Mar 1997	$112.80M	+741.8%
Dec 1996	$13.40M	-87.7%
Sep 1996	$109.10M	-5.6%
Jun 1996	$115.60M	+79.5%
Mar 1996	$64.40M	+126.0%
Dec 1995	$28.50M	-63.8%
Sep 1995	$78.70M	+4.7%
Jun 1995	$75.20M	+1.3%
Mar 1995	$74.20M	+96.3%
Dec 1994	$37.80M	+18.9%
Sep 1994	$31.80M	+3.6%
Jun 1994	$30.70M	+3.4%
Mar 1994	$29.70M	-12.4%
Dec 1993	$33.90M	+19.4%
Sep 1993	$28.40M	+2.9%
Jun 1993	$27.60M	+10.4%
Mar 1993	$25.00M	-6.4%
Dec 1992	$26.70M	+4.3%
Sep 1992	$25.60M	+10.3%
Jun 1992	$23.20M	+5.5%
Mar 1992	$22.00M	+123.0%
Dec 1991	-$95.70M	-259.8%
Sep 1991	$59.90M	+7.2%
Jun 1991	$55.90M	+10.7%
Mar 1991	$50.50M	-

FAQ

What is the current quarterly EBITDA of BSX?
As of today, BSX quarterly EBITDA is $1.58B
What is BSX quarterly EBITDA most recent change?
BSX quarterly EBITDA was up +14.03% on December 31, 2025
What is 1-year change in BSX quarterly EBITDA?
BSX quarterly EBITDA is up +68.30% year-over-year
How far is BSX quarterly EBITDA from its all-time high?
BSX quarterly EBITDA is currently at its all-time high
How does BSX quarterly EBITDA rank versus sector peers?
BSX quarterly EBITDA is higher than 98.08% of companies in Healthcare sector
When is BSX next earnings release?
The next earnings release for BSX is on April 22, 2026

TTM EBITDA

$5.44B$640.00M+13.34%

December 31, 2025

Summary

Current Value: As of today, BSX TTM EBITDA is $5.44B, up +13.34% on December 31, 2025
Historical Performance: BSX TTM EBITDA is up +38.61% year-over-year, up +82.58% over the past 3 years
All-Time High Comparison: BSX TTM EBITDA is currently at its all-time high
3-Year Low Comparison: BSX TTM EBITDA is +82.58% above its 3-year low of $2.98B reached on an earlier date
Sector Comparison: BSX TTM EBITDA is higher than 97.80% of companies in Healthcare sector

Performance

BSX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Dec 31, 25	$5.44B	+13.3%	+38.6%	+82.6%	+216.2%
Annual EBITDA	Dec 31, 25	$5.44B	–	+39.3%	+83.8%	+215.7%
Quarterly EBITDA	Dec 31, 25	$1.58B	+14.0%	+68.3%	+112.3%	+240.6%
Price	Feb 27, 26	$76.85	-22.4%	-26.0%	+62.6%	+98.3%
PE Ratio	Feb 27, 26	39.63	-25.2%	-52.4%	-62.5%	–
TTM Revenue	Dec 31, 25	$20.08B	+3.8%	+19.9%	+58.3%	+102.5%
TTM EPS	Dec 31, 25	$1.94	+3.7%	+55.4%	+334.1%	+1677.8%
TTM EBIT	Dec 31, 25	$3.90B	+13.1%	+47.0%	+111.6%	+552.2%
TTM Net Income	Dec 31, 25	$2.89B	+3.9%	+56.8%	+313.7%	+2180.6%

TTM EBITDA Highs

BSX TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$5.44B	Dec 31, 25	at high
3Y	$5.44B	Dec 31, 25	at high
5Y	$5.44B	Dec 31, 25	at high
All	$5.44B	Dec 31, 25	at high

TTM EBITDA Lows

BSX TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$3.92B	N/A	+38.6%
3Y	$2.98B	N/A	+82.6%
5Y	$1.72B	N/A	+216.2%
All	-$24.90M	Sep 30, 92	>+9999.0%

TTM EBITDA History

Month	Value	Change
Dec 2025	$5.44B	+13.3%
Sep 2025	$4.80B	+9.1%
Jun 2025	$4.40B	+4.8%
Mar 2025	$4.20B	+7.0%
Dec 2024	$3.92B	+1.7%
Sep 2024	$3.86B	+3.3%
Jun 2024	$3.74B	+5.9%
Mar 2024	$3.53B	+4.4%
Dec 2023	$3.38B	+3.9%
Sep 2023	$3.25B	+3.7%
Jun 2023	$3.14B	+2.9%
Mar 2023	$3.05B	+2.3%
Dec 2022	$2.98B	-0.1%
Sep 2022	$2.98B	+1.0%
Jun 2022	$2.95B	-0.4%
Mar 2022	$2.97B	+3.6%
Dec 2021	$2.86B	+11.0%
Sep 2021	$2.58B	+7.1%
Jun 2021	$2.41B	+30.3%
Mar 2021	$1.85B	+7.4%
Dec 2020	$1.72B	-12.2%
Sep 2020	$1.96B	-5.4%
Jun 2020	$2.07B	-17.9%
Mar 2020	$2.52B	-5.9%
Dec 2019	$2.68B	+1.2%
Sep 2019	$2.65B	+0.8%
Jun 2019	$2.63B	+0.0%
Mar 2019	$2.62B	-0.3%
Dec 2018	$2.63B	+0.1%
Sep 2018	$2.63B	+1.8%
Jun 2018	$2.58B	+2.5%
Mar 2018	$2.52B	+6.4%
Dec 2017	$2.37B	+6.0%
Sep 2017	$2.23B	+2.1%
Jun 2017	$2.19B	+4.5%
Mar 2017	$2.09B	+2.0%
Dec 2016	$2.05B	+27.6%
Sep 2016	$1.61B	+8.7%
Jun 2016	$1.48B	+8.8%
Mar 2016	$1.36B	+5.3%
Dec 2015	$1.29B	-16.5%
Sep 2015	$1.54B	+1.8%
Jun 2015	$1.52B	-0.3%
Mar 2015	$1.52B	+0.7%
Dec 2014	$1.51B	-2.6%
Sep 2014	$1.55B	-0.2%
Jun 2014	$1.55B	-1.3%
Mar 2014	$1.57B	+0.8%
Dec 2013	$1.56B	-3.3%
Sep 2013	$1.61B	-1.8%
Jun 2013	$1.64B	-0.7%
Mar 2013	$1.65B	-1.4%
Dec 2012	$1.68B	+1.2%
Sep 2012	$1.66B	+0.4%
Jun 2012	$1.65B	-3.3%
Mar 2012	$1.71B	-7.2%
Dec 2011	$1.84B	-4.3%
Sep 2011	$1.92B	-3.0%
Jun 2011	$1.98B	+1.7%
Mar 2011	$1.95B	+3.2%
Dec 2010	$1.89B	-2.2%
Sep 2010	$1.93B	-2.9%
Jun 2010	$1.99B	-4.7%
Mar 2010	$2.09B	+1.4%
Dec 2009	$2.06B	+2.5%
Sep 2009	$2.01B	+1.2%
Jun 2009	$1.99B	-0.5%
Mar 2009	$2.00B	-7.6%
Dec 2008	$2.16B	-4.3%
Sep 2008	$2.26B	-0.3%

Month	Value	Change
Jun 2008	$2.26B	-0.8%
Mar 2008	$2.28B	+4.5%
Dec 2007	$2.18B	+1.3%
Sep 2007	$2.15B	+4.4%
Jun 2007	$2.06B	+5.6%
Mar 2007	$1.95B	-3.1%
Dec 2006	$2.02B	+0.9%
Sep 2006	$2.00B	-5.6%
Jun 2006	$2.12B	-6.2%
Mar 2006	$2.26B	-3.4%
Dec 2005	$2.34B	+0.3%
Sep 2005	$2.33B	+3.1%
Jun 2005	$2.26B	+3.1%
Mar 2005	$2.19B	+20.1%
Dec 2004	$1.83B	+20.3%
Sep 2004	$1.52B	+20.4%
Jun 2004	$1.26B	+35.7%
Mar 2004	$929.00M	+10.9%
Dec 2003	$838.00M	-4.3%
Sep 2003	$876.00M	+5.3%
Jun 2003	$832.00M	+8.1%
Mar 2003	$770.00M	+7.5%
Dec 2002	$716.00M	-10.3%
Sep 2002	$798.00M	+3.1%
Jun 2002	$774.00M	+6.9%
Mar 2002	$724.00M	-0.1%
Dec 2001	$725.00M	+23.5%
Sep 2001	$587.00M	-6.2%
Jun 2001	$626.00M	-15.1%
Mar 2001	$737.00M	-6.4%
Dec 2000	$787.00M	-7.4%
Sep 2000	$850.00M	+4.0%
Jun 2000	$817.00M	-2.4%
Mar 2000	$837.00M	-2.3%
Dec 1999	$857.00M	+6.9%
Sep 1999	$801.89M	+2.2%
Jun 1999	$784.86M	+16.1%
Mar 1999	$675.86M	+17.6%
Dec 1998	$574.86M	+42.4%
Sep 1998	$403.77M	+1.6%
Jun 1998	$397.30M	-5.4%
Mar 1998	$420.10M	-0.4%
Dec 1997	$421.90M	+8.3%
Sep 1997	$389.50M	+4.1%
Jun 1997	$374.10M	+6.6%
Mar 1997	$350.90M	+16.0%
Dec 1996	$302.50M	-4.8%
Sep 1996	$317.60M	+10.6%
Jun 1996	$287.20M	+16.4%
Mar 1996	$246.80M	-3.8%
Dec 1995	$256.60M	-3.5%
Sep 1995	$265.90M	+21.4%
Jun 1995	$219.00M	+25.5%
Mar 1995	$174.50M	+34.2%
Dec 1994	$130.00M	+3.1%
Sep 1994	$126.10M	+2.8%
Jun 1994	$122.70M	+2.6%
Mar 1994	$119.60M	+4.1%
Dec 1993	$114.90M	+6.7%
Sep 1993	$107.70M	+2.7%
Jun 1993	$104.90M	+4.4%
Mar 1993	$100.50M	+3.1%
Dec 1992	$97.50M	+491.6%
Sep 1992	-$24.90M	-364.9%
Jun 1992	$9.40M	-77.7%
Mar 1992	$42.10M	-40.4%
Dec 1991	$70.60M	-57.5%
Sep 1991	$166.30M	+56.3%
Jun 1991	$106.40M	+110.7%
Mar 1991	$50.50M	-

FAQ

What is the current TTM EBITDA of BSX?
As of today, BSX TTM EBITDA is $5.44B
What is BSX TTM EBITDA most recent change?
BSX TTM EBITDA was up +13.34% on December 31, 2025
What is 1-year change in BSX TTM EBITDA?
BSX TTM EBITDA is up +38.61% year-over-year
How far is BSX TTM EBITDA from its all-time high?
BSX TTM EBITDA is currently at its all-time high
How does BSX TTM EBITDA rank versus sector peers?
BSX TTM EBITDA is higher than 97.80% of companies in Healthcare sector
When is BSX next earnings release?
The next earnings release for BSX is on April 22, 2026

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + Depreciation & Amortization

Data Sources & References

BSX Official Website www.bostonscientific.com
Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
BSX Profile on Yahoo Finance finance.yahoo.com/quote/BSX
BSX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bsx